• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜环境调节P2Y12受体的配体结合倾向。

Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor.

作者信息

Haghighi Fatemeh, Yesylevskyy Semen, Davani Siamak, Ramseyer Christophe

机构信息

Laboratoire Chrono Environnement UMR CNRS 6249, Université de Bourgogne Franche-Comté, 16 route de Gray, CEDEX, 25030 Besançon, France.

Unité de Recherche EA 3920, Université de Bourgogne Franche-Comté, 19 rue Ambroise Paré, CEDEX, 25000 Besançon, France.

出版信息

Pharmaceutics. 2021 Apr 9;13(4):524. doi: 10.3390/pharmaceutics13040524.

DOI:10.3390/pharmaceutics13040524
PMID:33918934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8069422/
Abstract

The binding of natural ligands and synthetic drugs to the P2Y12 receptor is of great interest because of its crucial role in platelets activation and the therapy of arterial thrombosis. Up to now, all computational studies of P2Y12 concentrated on the available crystal structures, while the role of intrinsic protein dynamics and the membrane environment in the functioning of P2Y12 was not clear. In this work, we performed all-atom molecular dynamics simulations of the full-length P2Y receptor in three different membrane environments and in two possible conformations derived from available crystal structures. The binding of ticagrelor, its two major metabolites, adenosine diphosphate (ADP) and 2-Methylthioadenosine diphosphate (2MeS-ADP) as agonist, and ethyl 6-[4-(benzylsulfonylcarbamoyl)piperidin-1-yl]-5-cyano-2-methylpyridine-3-carboxylate (AZD1283)as antagonist were assessed systematically by means of ensemble docking. It is shown that the binding of all ligands becomes systematically stronger with the increase of the membrane rigidity. Binding of all ligands to the agonist-bound-like conformations is systematically stronger in comparison to antagonist-bound-likes ones. This is dramatically opposite to the results obtained for static crystal structures. Our results show that accounting for internal protein dynamics, strongly modulated by its lipid environment, is crucial for correct assessment of the ligand binding to P2Y12.

摘要

天然配体和合成药物与P2Y12受体的结合备受关注,因为它在血小板活化和动脉血栓治疗中起着关键作用。到目前为止,所有关于P2Y12的计算研究都集中在现有的晶体结构上,而内在蛋白质动力学和膜环境在P2Y12功能中的作用尚不清楚。在这项工作中,我们在三种不同的膜环境以及从现有晶体结构衍生出的两种可能构象下,对全长P2Y受体进行了全原子分子动力学模拟。通过系综对接系统地评估了替格瑞洛及其两种主要代谢产物二磷酸腺苷(ADP)和2-甲硫基二磷酸腺苷(2MeS-ADP)作为激动剂,以及6-[4-(苄基磺酰基氨基甲酰基)哌啶-1-基]-5-氰基-2-甲基吡啶-3-羧酸乙酯(AZD1283)作为拮抗剂的结合情况。结果表明,随着膜刚性的增加,所有配体的结合都系统性地增强。与拮抗剂结合样构象相比,所有配体与激动剂结合样构象的结合系统性地更强。这与静态晶体结构得到的结果截然不同。我们的结果表明,考虑到受其脂质环境强烈调节的内部蛋白质动力学,对于正确评估配体与P2Y12的结合至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/da86e520421c/pharmaceutics-13-00524-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/28cb1639d1e7/pharmaceutics-13-00524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/97b767d97ccc/pharmaceutics-13-00524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/f1f65c7e4d4e/pharmaceutics-13-00524-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/b06f5fed733b/pharmaceutics-13-00524-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/41b61b8fc6b8/pharmaceutics-13-00524-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/9ea750c5691a/pharmaceutics-13-00524-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/da86e520421c/pharmaceutics-13-00524-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/28cb1639d1e7/pharmaceutics-13-00524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/97b767d97ccc/pharmaceutics-13-00524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/f1f65c7e4d4e/pharmaceutics-13-00524-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/b06f5fed733b/pharmaceutics-13-00524-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/41b61b8fc6b8/pharmaceutics-13-00524-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/9ea750c5691a/pharmaceutics-13-00524-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/8069422/da86e520421c/pharmaceutics-13-00524-g007.jpg

相似文献

1
Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor.膜环境调节P2Y12受体的配体结合倾向。
Pharmaceutics. 2021 Apr 9;13(4):524. doi: 10.3390/pharmaceutics13040524.
2
P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.P2Y12 拮抗剂替卡格雷抑制激活的血小板释放促凝细胞外囊泡。
Cardiol J. 2019;26(6):782-789. doi: 10.5603/CJ.a2018.0045. Epub 2018 Apr 19.
3
Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information.根据X射线结构信息对P2Y12受体的配体识别进行建模。
J Comput Aided Mol Des. 2015 Aug;29(8):737-56. doi: 10.1007/s10822-015-9858-z. Epub 2015 Jul 21.
4
Reorganization of platelet membrane sphingomyelins by adenosine diphosphate and ticagrelor.血小板膜神经鞘磷脂由二磷酸腺苷和替格瑞洛重组。
Chem Phys Lipids. 2018 Nov;216:25-29. doi: 10.1016/j.chemphyslip.2018.09.008. Epub 2018 Sep 14.
5
ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.二磷酸腺苷(ADP)分泌及随后的P2Y12受体信号传导在凝血酶诱导的人血小板细胞外调节蛋白激酶2(ERK2)激活中起关键作用。
Thromb Haemost. 2004 Jul;92(1):114-23. doi: 10.1160/TH03-12-0729.
6
Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.二磷酸腺苷(ADP)诱导人血小板生成血栓素A2需要通过整合素α(IIb)β3和ADP受体进行协调信号传导。
Blood. 2002 Jan 1;99(1):193-8. doi: 10.1182/blood.v99.1.193.
7
Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin.蛋白酶激活受体1和4以及糖蛋白Ib-IX-V在凝血酶对血小板Rap1B的非G(i)依赖性激活中的作用。
J Biol Chem. 2004 Jun 11;279(24):25299-306. doi: 10.1074/jbc.M313199200. Epub 2004 Apr 12.
8
Platelet collagen receptor integrin alpha2beta1 activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change.血小板胶原受体整合素α2β1的激活涉及ADP受体亚型P2Y1和P2Y12的不同参与,但与细胞内钙变化无关。
Eur J Biochem. 2001 Jun;268(12):3513-22. doi: 10.1046/j.1432-1327.2001.02252.x.
9
Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane.替格瑞洛对血小板质膜 P2Y1 和 P2Y12 定位及胆固醇水平的影响。
Platelets. 2018 Nov;29(7):709-715. doi: 10.1080/09537104.2017.1356453. Epub 2017 Oct 11.
10
The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays.基于聚集和流式细胞术检测的 P2Y12 抑制对血小板活化的影响。
Platelets. 2017 Sep;28(6):567-575. doi: 10.1080/09537104.2016.1246713. Epub 2016 Nov 25.

引用本文的文献

1
Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design.药物研究中分子动力学的机理理解2:药物设计中的脂质膜
Pharmaceuticals (Basel). 2021 Oct 19;14(10):1062. doi: 10.3390/ph14101062.

本文引用的文献

1
Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite.抗血小板药物对血小板质膜脂类组成的影响:替格瑞洛及其活性代谢物的脂质组学研究
Int J Mol Sci. 2021 Jan 31;22(3):1432. doi: 10.3390/ijms22031432.
2
Validation of an HPLC-MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice.建立 HPLC-MS/MS 法测定人血浆替格瑞洛及其活性代谢物浓度的方法学研究及其用于临床实践的评估
Molecules. 2021 Jan 8;26(2):278. doi: 10.3390/molecules26020278.
3
Cholesterol-Rich Microdomains Contribute to PAR1 Signaling in Platelets Despite a Weak Localization of the Receptor in These Microdomains.
富含胆固醇的微域有助于血小板 PAR1 信号传导,尽管受体在这些微域中的定位较弱。
Int J Mol Sci. 2020 Oct 29;21(21):8065. doi: 10.3390/ijms21218065.
4
Albumin-driven disassembly of lipidic nanoparticles: the specific case of the squalene-adenosine nanodrug.白蛋白驱动的脂质纳米粒解体:角鲨烯-腺嘌呤核苷纳米药物的特殊情况。
Nanoscale. 2020 Jan 28;12(4):2793-2809. doi: 10.1039/c9nr06485k. Epub 2020 Jan 21.
5
Reorganization of platelet membrane sphingomyelins by adenosine diphosphate and ticagrelor.血小板膜神经鞘磷脂由二磷酸腺苷和替格瑞洛重组。
Chem Phys Lipids. 2018 Nov;216:25-29. doi: 10.1016/j.chemphyslip.2018.09.008. Epub 2018 Sep 14.
6
Ticagrelor - toward more efficient platelet inhibition and beyond.替格瑞洛——迈向更有效的血小板抑制及其他方面。
Ther Clin Risk Manag. 2018 Jan 17;14:129-140. doi: 10.2147/TCRM.S152369. eCollection 2018.
7
Low-Density Lipoproteins and Human Serum Albumin as Carriers of Squalenoylated Drugs: Insights from Molecular Simulations.低密度脂蛋白和人血清白蛋白作为鲨烯酰化药物的载体:分子模拟的见解。
Mol Pharm. 2018 Feb 5;15(2):585-591. doi: 10.1021/acs.molpharmaceut.7b00952. Epub 2018 Jan 17.
8
Template-based and free modeling of I-TASSER and QUARK pipelines using predicted contact maps in CASP12.在蛋白质结构预测技术评估第12轮(CASP12)中,基于模板以及I-TASSER和QUARK流程的自由建模,并使用预测的接触图。
Proteins. 2018 Mar;86 Suppl 1(Suppl 1):136-151. doi: 10.1002/prot.25414. Epub 2017 Nov 14.
9
Selective Inhibition of STAT3 with Respect to STAT1: Insights from Molecular Dynamics and Ensemble Docking Simulations.相对于STAT1对STAT3的选择性抑制:来自分子动力学和系综对接模拟的见解。
J Chem Inf Model. 2016 Aug 22;56(8):1588-96. doi: 10.1021/acs.jcim.6b00198. Epub 2016 Aug 9.
10
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field.使用CHARMM36加和力场的NAMD、GROMACS、AMBER、OpenMM和CHARMM/OpenMM模拟的CHARMM-GUI输入生成器。
J Chem Theory Comput. 2016 Jan 12;12(1):405-13. doi: 10.1021/acs.jctc.5b00935. Epub 2015 Dec 3.